122 related articles for article (PubMed ID: 1719464)
1. Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines.
Garcia R; Parikh NU; Saya H; Gallick GE
Oncogene; 1991 Nov; 6(11):1983-9. PubMed ID: 1719464
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of pp60c-src protein kinase by herbimycin A in polyomavirus middle tumor antigen-transformed cells.
Yang YW; Chang YH
Anticancer Res; 1997; 17(5A):3273-9. PubMed ID: 9413159
[TBL] [Abstract][Full Text] [Related]
3. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
[TBL] [Abstract][Full Text] [Related]
4. Analysis of pp60c-src in human colon carcinoma and normal human colon mucosal cells.
Bolen JB; Veillette A; Schwartz AM; Deseau V; Rosen N
Oncogene Res; 1987 Jul; 1(2):149-68. PubMed ID: 2453014
[TBL] [Abstract][Full Text] [Related]
5. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S
Cancer Res; 1989 Jan; 49(2):331-4. PubMed ID: 2910452
[TBL] [Abstract][Full Text] [Related]
6. Effect of herbimycin A on renal cancer cell growth.
Tsuji A; Asano T; Suzuki S; Aoyagi T; Hayakawa M; Nakamura H
Nihon Jinzo Gakkai Shi; 1996 May; 38(5):198-201. PubMed ID: 8699609
[TBL] [Abstract][Full Text] [Related]
7. Benzoquinonoid ansamycins possess selective tumoricidal activity unrelated to src kinase inhibition.
Whitesell L; Shifrin SD; Schwab G; Neckers LM
Cancer Res; 1992 Apr; 52(7):1721-8. PubMed ID: 1551101
[TBL] [Abstract][Full Text] [Related]
8. c-Yes tyrosine kinase activity in human colon carcinoma.
Park J; Meisler AI; Cartwright CA
Oncogene; 1993 Oct; 8(10):2627-35. PubMed ID: 7690925
[TBL] [Abstract][Full Text] [Related]
9. Overexpression and activation of the tyrosine kinase Src in human pancreatic carcinoma.
Lutz MP; Esser IB; Flossmann-Kast BB; Vogelmann R; Lührs H; Friess H; Büchler MW; Adler G
Biochem Biophys Res Commun; 1998 Feb; 243(2):503-8. PubMed ID: 9480838
[TBL] [Abstract][Full Text] [Related]
10. Site-specific differences in pp60c-src activity in human colorectal metastases.
Termuhlen PM; Curley SA; Talamonti MS; Saboorian MH; Gallick GE
J Surg Res; 1993 Apr; 54(4):293-8. PubMed ID: 7687314
[TBL] [Abstract][Full Text] [Related]
11. Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src.
Staley CA; Parikh NU; Gallick GE
Cell Growth Differ; 1997 Mar; 8(3):269-74. PubMed ID: 9056668
[TBL] [Abstract][Full Text] [Related]
12. Effects of herbimycin A derivatives on growth and differentiation of K562 human leukemic cells.
Honma Y; Kasukabe T; Hozumi M; Shibata K; Omura S
Anticancer Res; 1992; 12(1):189-92. PubMed ID: 1567167
[TBL] [Abstract][Full Text] [Related]
13. Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.
Foss FM; Veillette A; Sartor O; Rosen N; Bolen JB
Oncogene Res; 1989; 5(1):13-23. PubMed ID: 2476706
[TBL] [Abstract][Full Text] [Related]
14. Analysis of pp60c-src tyrosine kinase activity and phosphotyrosyl phosphatase activity in human colon carcinoma and normal human colon mucosal cells.
DeSeau V; Rosen N; Bolen JB
J Cell Biochem; 1987 Oct; 35(2):113-28. PubMed ID: 2448318
[TBL] [Abstract][Full Text] [Related]
15. Effects of doxorubicin on pp60c-src kinase activity in polyoma virus MT antigen transformed cells.
Yang YW; Chang YH
Anticancer Res; 1994; 14(6B):2529-35. PubMed ID: 7532928
[TBL] [Abstract][Full Text] [Related]
16. Herbimycin A inhibits the association of p60v-src with the cytoskeletal structure and with phosphatidylinositol 3' kinase.
Hamaguchi M; Xiao H; Uehara Y; Ohnishi Y; Nagai Y
Oncogene; 1993 Mar; 8(3):559-64. PubMed ID: 8382356
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1.
Uehara Y; Murakami Y; Sugimoto Y; Mizuno S
Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877
[TBL] [Abstract][Full Text] [Related]
18. Protein-tyrosine kinase activity and pp60v-src expression in whole cells measured by flow cytometry.
Preis PN; Waldman FM; Frackelton AR; Saya H; Levin VA
Cancer Res; 1988 Aug; 48(16):4633-8. PubMed ID: 3135116
[TBL] [Abstract][Full Text] [Related]
19. Herbimycin A, an inhibitor of tyrosine kinase, prolongs survival of mice inoculated with myeloid leukemia C1 cells with high expression of v-abl tyrosine kinase.
Honma Y; Okabe-Kado J; Kasukabe T; Hozumi M; Kodama H; Kajigaya S; Suda T; Miura Y
Cancer Res; 1992 Jul; 52(14):4017-20. PubMed ID: 1617678
[TBL] [Abstract][Full Text] [Related]
20. Activity of pp60c-src in 60 different cell lines derived from human tumors.
Budde RJ; Ke S; Levin VA
Cancer Biochem Biophys; 1994 Oct; 14(3):171-5. PubMed ID: 7537173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
